Literature DB >> 33423807

Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis.

A Verschueren1, A-M Grapperon2, E Delmont2, S Attarian2.   

Abstract

Although they are common symptoms of ALS, there is little information on the prevalence of spasticity and spasticity-related pain. Consecutive patients were prospectively recruited from an ALS referral center. Clinical assessment, functional scores, features of spasticity-related pains has been recorded. In a cohort of 150 patients, 36% presented with spasticity. Spastic patients were younger, with a longer duration of disease. Spasticity accelerates the functional decline of patients. Spasticity-related pain was reported in 42.5% of spastic patients with mild pain. However, 16.7% of spastic patients presented significant pain with numeric rating scale≥4. More clinical trials are needed to treat spasticity more effectively and to relieve ALS patients.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ALS; Motor neuron disease; Muscle spasticity; Neuropathic pain; Pain

Year:  2021        PMID: 33423807     DOI: 10.1016/j.neurol.2020.08.009

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Pain in amyotrophic lateral sclerosis: a narrative review.

Authors:  Soyoung Kwak
Journal:  J Yeungnam Med Sci       Date:  2022-06-08

2.  Pain-Related Factors and Their Impact on Quality of Life in Chinese Patients With Amyotrophic Lateral Sclerosis.

Authors:  Ran An; Yuan Wu; Yi Li; Xin Li; Shaolong Ai; Yanming Xu; Chengqi He
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

3.  The Evaluation of Pain with Nociceptive and Neuropathic Characteristics from Three Different Perspectives in Amyotrophic Lateral Sclerosis Patients: A Case Controlled Observational Study in Southwestern China.

Authors:  Ran An; Yan Li; Xianghua He; Cheng Li; Xin Li; Yanming Xu; Chengqi He
Journal:  Neural Plast       Date:  2021-07-30       Impact factor: 3.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.